Validation of a systemic lupus activity questionnaire (SLAQ) for population studies

Lupus

Volumn 12, Issue 4, 2003, Pages 280-286

  Karlson, E W ^a,d   Daltroy, L H ^a   Rivest, C ^a   Ramsey Goldman, R ^b   Wright, E A ^a   Partridge, A J ^a   Liang, M H ^a   Fortin, P R ^c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c TORONTO WESTERN HOSPITAL   (Canada)

^d NONE   (United States)

Author keywords

Clinical trials; Clinimetrics; Disease activity; Outcome; Self assessment; SLE

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; FEMALE; HEALTH CARE COST; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; MEASUREMENT; MEDICAL SPECIALIST; POPULATION RESEARCH; PRIORITY JOURNAL; QUESTIONNAIRE; SYSTEMIC LUPUS ERYTHEMATOSUS; VALIDATION PROCESS;

ADULT; CLINICAL TRIALS; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MULTIVARIATE ANALYSIS; PHYSICIANS; PREDICTIVE VALUE OF TESTS; QUESTIONNAIRES; RHEUMATOLOGY; SEVERITY OF ILLNESS INDEX;

EID: 0037262877     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203303lu332oa     Document Type: Article

References (14)

1. Karlson EW, Daltroy LH, Lew RA, Wright EA, Partridge AJ, Roberts WN et al. The relationship of socioeconomic status, race, and modifiable risk factors to outcomes in patients with systemic lupus erythematosus. Arthritis Rheum 1997; 40: 47-56.
2. Smolen JS, Strand V, Cardiel M, Edworthy S, Furst D, Glasman D et al. Randomized clinical trials and longitudinal observational studies in systemic lupus erythematosus: consensus on a preliminary core set of outcome domains. J Rheum 1999; 26: 504-505.
3. Liang MH, Socher SA, Larson MG, Schur PH. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum 1989; 32: 1107-1118.
4. Bae SC, Koh H-K, Chang D-K, Kim M-H, Part J-K, Kim SY. Reliability and validity of systemic lupus activity measure-revised (SLAM-R) for measuring clinical disease activity in systemic lupus erythematosus. Lupus 2002; 10: 405-409.
5. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992; 35: 630-640.
6. Hay EM, Bacon PA, Gordon C, Isenberg DA, Maddison P, Snaith ML et al. The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus. Q J Med 1993; 86: 447-458.
7. Petri M, Hellmann D, Hochberg M. Validity and reliability of lupus activity measures in the routine clinic setting. J Rheumatol 1992; 19: 53-59.
8. Vitali C, Bencivelli W, Mosca M, Carrai P, Sereni M, Bombardieri S. Development of a clinical chart to compute different disease activity indices for systemic lupus erythematosus. J Rheumatol 1999; 26: 498-501.
9. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
10. Karlson EW, Rivest C, Ramsey-Goldman R, Fortin PR, Shadick NA, Partridge AT, Lew RA, Wright EA, Daltroy LH, Liang MH. Validation of a self-administered SLE disease activity measure (SA-SLAM) for population studies. Arthritis Rheum 1996; 39: S209.
11. Abrahamowicz M, Fortin PR, du Berger R, Nayak V, Neville C, Liang MH. The relationship between disease activity and expert physician's decision to start major treatment in active systemic lupus erythematosus: a decision aid for development of entry criteria for clinical trials. J Rheum 1998; 25: 277-284.
12. Neville C, Clarke AE, Joseph L, Belisle P, Ferland D, Fortin P. Learning from discordance in patient and physician global assessments of systemic lupus erythematosus disease activity. J Rheumatol 2000; 27: 675-679.
13. Chang ER, Abramowicz M, Ferland D, Fortin PR, for CaNIOS investigators. Organ manifestations influence differently the responsiveness of two lupus disease activity measures, according to patients' or physicians' evaluations of recent lupus activity. J Rheumatol 2002; 29: 2350-2358.
14. Nunnally JC, Bernstein IH. Psychometric Theory, 3rd edn. McGraw-Hill: New York. 1994.